A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis
about
Antiviral perspectives for chikungunya virusProduction of Chikungunya Virus-Like Particles and Subunit Vaccines in Insect CellsCross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccineInfectious Chikungunya Virus in the Saliva of Mice, Monkeys and HumansDNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in miceExposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacyPrime-boost immunization strategies against Chikungunya virusMultiple immune factors are involved in controlling acute and chronic chikungunya virus infectionCCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritisAntiviral Hammerhead Ribozymes Are Effective for Developing Transgenic Suppression of Chikungunya Virus in Aedes aegypti MosquitoesChikungunya vaccines in developmentRNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammationDevelopment of Vaccines for Chikungunya Fever.Next generation sequencing of DNA-launched Chikungunya vaccine virus.Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice.Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.Effective chikungunya virus-like particle vaccine produced in insect cells.Enhanced production of Chikungunya virus-like particles using a high-pH adapted spodoptera frugiperda insect cell line.Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.Chikungunya virus: evolution and genetic determinants of emergence.A chimeric vesiculo/alphavirus is an effective alphavirus vaccineChikungunya virus and prospects for a vaccine.Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.Genomes to hits in silico - a country path today, a highway tomorrow: a case study of chikungunya.Chikungunya virus transmission between Aedes albopictus and laboratory mice.A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology.Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies.Chikungunya Virus Vaccines: Viral Vector-Based Approaches.Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology.Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201).Vaccine and Therapeutic Options To Control Chikungunya Virus.A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approachCellular and Molecular Immune Response to Chikungunya Virus Infection
P2860
Q21284682-D0556C6C-A697-46C1-8AB7-1D4889624291Q24261442-23730F28-9E7E-4283-B64A-D147A8745DEBQ24276414-B8627512-480A-47A0-BCF1-BF2F70EB3958Q24288650-B257B3DC-E40C-4221-92B5-50D682E1C048Q24701765-C2096B51-D855-498C-9E52-5C80CAF9E124Q24701766-5205FE55-4A02-4A14-8327-7DE6FB70B646Q24701774-3371DFFD-F1C1-431A-82CE-985D89806096Q24701792-E2BDEF9B-DB6B-438D-A4A4-B49DC385AAE8Q24701793-2A92997B-11E1-45A1-9C35-CE900E879A49Q26314624-D1555CD9-DE50-4970-B781-3B493C73D957Q26700081-4B5D8F9C-0180-4730-B314-874B9012C9D7Q28804081-4A565D3E-91F6-49B6-B4FF-493B868B034BQ30240191-AD26EA88-5DEB-43C6-A15D-F84605053DDDQ30384231-66394353-C58A-4671-B82C-227CFE2B2FFFQ30516488-9BAE577B-595E-4E9D-81E3-745E7B1DB6D1Q33684369-97B20A65-7E43-4EE7-B964-D972D7923946Q33945612-7CD6C014-8E5F-46C1-A11B-B0AB717D2852Q34394530-955E860F-295E-439B-B8D3-D5935D9F732FQ34630576-915852D2-1FF3-4734-91B0-B1F5E268361CQ35142715-3A0A6EBF-7B18-46F6-89CE-BAB625D8152CQ35238179-8423BA9B-4B68-49BB-A246-BC4EE2A9C2CDQ35240173-B4D6C449-BF09-4FB0-BE6E-9C278064AA5BQ36506753-F2E34C55-2AE7-4FF8-A9E3-99DA8FE3E0E4Q36582816-4E3E4955-2226-4557-9C8F-6652C982938CQ37065242-51515F5A-CD31-474F-B0F3-27A3F7C602E9Q37319331-03091936-431C-4245-AC09-2FEC0AF00A98Q37349608-F3F8707C-FB3C-4673-893E-067E8A65D6B4Q37643733-9DC1B065-F083-4F0F-A594-D0826C192FA8Q37993737-4B148A15-6A4A-4E90-80DA-105F68E3CC13Q38666344-3F8937A8-DC98-438B-BEEB-6AE8AAFC4263Q39128566-E44FBD77-BED3-443C-BA99-1113B4661210Q40077678-B64604C0-6196-4141-BB35-697AF034CBD3Q40117821-D0B60FE3-C2F5-47AD-8BDA-AB0D530298B4Q40207010-6BA0CF33-6F62-410D-9016-33A21E0BD83FQ47566099-2B9E3D3B-53E5-44E9-98D6-B2B745127C43Q51336011-39911026-3EE9-4EAE-9308-47DE0B1079D0Q58111653-C53B46AB-CCF9-43D2-ABAC-3907A9FD1EA6Q58575620-AA8E1BB8-68CB-4E40-8680-6E4F8213BCD7
P2860
A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A complex adenovirus vaccine a ...... against viraemia and arthritis
@ast
A complex adenovirus vaccine a ...... against viraemia and arthritis
@en
A complex adenovirus vaccine a ...... against viraemia and arthritis
@nl
type
label
A complex adenovirus vaccine a ...... against viraemia and arthritis
@ast
A complex adenovirus vaccine a ...... against viraemia and arthritis
@en
A complex adenovirus vaccine a ...... against viraemia and arthritis
@nl
prefLabel
A complex adenovirus vaccine a ...... against viraemia and arthritis
@ast
A complex adenovirus vaccine a ...... against viraemia and arthritis
@en
A complex adenovirus vaccine a ...... against viraemia and arthritis
@nl
P2093
P2860
P1433
P1476
A complex adenovirus vaccine a ...... against viraemia and arthritis
@en
P2093
Adam Penn-Nicholson
Danher Wang
David Einfeld
Itaru Anraku
Jan Woraratanadharm
John Y Dong
Joy Gardner
Michael Sakalian
P2860
P304
P356
10.1016/J.VACCINE.2011.01.108
P407
P5008
P577
2011-02-12T00:00:00Z